# Crinetics Pharmaceuticals

Type: Company (CRNX)

Source: AI Intelligence Brief — https://getaibrief.com/entity/crinetics-pharmaceuticals
Canonical HTML page: https://getaibrief.com/entity/crinetics-pharmaceuticals

## Timeline

- **2026-02-26**: EU Expansion — Positive CHMP opinion received, enabling commercialization in the European Union.
- **2026-01-15**: Public Offering — Crinetics raises capital, bringing total cash position to $1.4 billion.
- **2025-12-31**: Q4 Milestone — Over 200 enrollment forms and 125 unique prescribers recorded for Palsonify.
- **2025-10-01**: Palsonify Launch — Crinetics initiates U.S. commercial launch of Palsonify for acromegaly.

## Recent coverage (2 stories)

### Samsung’s 1,800% Profit Jump Can’t Halt AI Stock Rout as Nasdaq Sinks 1.2%
2026-07-11 23:43:13 · Sentiment: Bearish · Impact: 7/10 · Sources: 8

Even a jaw-dropping 1,800% YoY operating profit forecast from Samsung couldn’t prop up AI stocks on July 7, as the sector’s inflated valuations met a harsh reality check. The 6.9% drop in Seoul and subsequent 6-10% declines in U.S. chipmakers signal that the AI industry must now prove its ROI potential to justify its sky-high market caps.
Full story: https://getaibrief.com/story/samsung-1800-profit-ai-selloff

### AI Infrastructure and Specialized Hardware Drive Q4 2025 Earnings Growth
2026-02-27 02:16:23 · Sentiment: Bullish · Impact: 7/10 · Sources: 11

Q4 2025 earnings reports highlight a strategic shift toward AI-integrated hardware and high-margin services, with Aeva securing a pivotal NVIDIA partnership and Arlo achieving record SaaS metrics. Meanwhile, Crinetics successfully launched Palsonify, backed by a massive $1.4 billion cash reserve to fuel global expansion.
Full story: https://getaibrief.com/story/ai-infrastructure-hardware-q4-2025-earnings

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getaibrief.com/guides/methodology for the full editorial methodology.